StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > While accumulation is boring, let’s play just for fun Today

<< Previous

Bullboard Posts

Next >>

Post by MarketMoneyon Mar 19, 2021 5:17am

242 Views

Post# 32835874

While accumulation is boring, let’s play just for fun Today

Let's have a poll on Q4 revenu......My guess is 2.7 millions dollars in revenu for Q4

I just did a quick calculation of 90 days give or take per 300 test per 100

What's your numbers! I'm curious to see all the inputs. There's no right or wrong but more join and better idea we have of global expectations :-)

For Today, I put my technical aside and let our fundamental point of view take over ;-)

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta